Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RECQL | P46063 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29602247 | 0.85 | RECQL (0.43) | RECQL | |
| SCHEMBL493365 | 0.85 | RECQL (0.43) | RECQL | |
| SCHEMBL29353925 | 0.75 | PDE1A (0.34) | RECQL | |
| SCHEMBL29487819 | 0.72 | TRPA1 (0.39) | RECQL | |
| SCHEMBL29520784 | 0.69 | HTR2C (0.50) | — | |
| SCHEMBL29994445 | 0.69 | RECQL (0.33) | RECQL | |
| SCHEMBL30224567 | 0.68 | RECQL (0.42) | RECQL | |
| SCHEMBL29520847 | 0.68 | RECQL (0.39) | RECQL | |
| SCHEMBL30168550 | 0.68 | CHEK1 (0.38) | — | |
| SCHEMBL30168569 | 0.68 | CHEK1 (0.49) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240294498-A1 | FACTOR XIIA INHIBITORS | LUNAC THERAPEUTICS LTD (GB) | 2024-09-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240294498-A1 | FACTOR XIIA INHIBITORS | F11, F13B, F7 | RECQL 3169/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.